Chemours (Germany) Top Insiders

Chemours Management Team Effectiveness

The company has return on total asset (ROA) of 0.0283 % which means that it generated a profit of $0.0283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6653) %, meaning that it generated substantial loss on money invested by shareholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The Chemours' current Other Current Assets is estimated to increase to about 85.7 M, while Total Assets are projected to decrease to roughly 7.8 B. The current Common Stock Shares Outstanding is estimated to decrease to about 129 M. The current Net Income Applicable To Common Shares is estimated to decrease to about 416.9 MChemours holds a total of 149.89 Million outstanding shares. The majority of Chemours Co outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemours to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemours. Please pay attention to any change in the institutional holdings of Chemours Co as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Chemours in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Chemours, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Chemours Workforce Comparison

The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07.

Chemours Benchmark Summation

Chemours Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Chemours often depends on how effective the management is. Chemours management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Chemours management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Chemours management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.